Immunome Stock (NASDAQ: IMNM) stock price, news, charts, stock research, profile.
Open | $16.39 |
Close | $16.51 |
Volume / Avg. | 705.04K / 958.31K |
Day Range | 15.85 - 16.67 |
52 Wk Range | 6.13 - 30.96 |
Market Cap | $990.83M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 69 |
Short Interest | 23.75% |
Days to Cover | 22.69 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Immunome (NASDAQ:IMNM) through any online brokerage.
Other companies in Immunome’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA), 89bio (NASDAQ:ETNB), 4D Molecular Therapeutics (NASDAQ:FDMT) and Cogent Biosciences (NASDAQ:COGT).
There is no analysis for Immunome.
Immunome has a consensus price target of $24.29.
The stock price for Immunome (NASDAQ: IMNM) is $16.5224 last updated July 26, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Immunome.
Immunome’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Immunome.
Immunome is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.